Earlier studies investigating properties of NLRP3, studied distinct effects of innate and adaptive inflammation independently, used toxin-related PD models or employed a prophylactic treatment regime [12, 18, 19, 22, 30]. Here, NLRP3 is linked to Parkinson disease.